SOVERINI, SIMONA
SOVERINI, SIMONA
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di IIa fascia
Simona Soverini; SOVERINI S.; S. SOVERINI; Soverini Simona
How I evaluate and treat resistance and relapse in CML
2026 Soverini, S.; Castagnetti, F.
Nilotinib versus imatinib with early switch from imatinib to nilotinib to obtain treatment-free remission in newly diagnosed chronic myeloid leukemia patients: the analysis of the first co-primary endpoint
2026 Castagnetti, F.; Breccia, M.; Abruzzese, E.; Bassan, R.; Binotto, G.; Bonifacio, M.; Caocci, G.; Capodanno, I.; Cavazzini, F.; Cimino, G.; Fazi, P.; Gozzini, A.; Iurlo, A.; Janssen, J. J. W. M.; Lunghi, M.; Marasca, R.; Martino, B.; Messina, M.; Muriano, F.; Paoloni, F.; Piciocchi, A.; Rosti, G.; Russo Rossi, A.; Saglio, G.; Sica, S.; Soverini, S.; Tafuri, A.; Vallisa, D.; Westerweel, P. E.; Pane, F.
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia
2025 Apperley, Jf; Milojkovic, D; Cross, Ncp; Hjorth-Hansen, H; Hochhaus, A; Kantarjian, H; Lipton, Jh; Malhotra, H; Niederwieser, D; Radich, J; Rousselot, P; Saussele, S; Schiffer, Ca; Silver, R; Soverini, S; Stenke, L; Turkina, A; Casado, Lf; Castagnetti, F; Cervantes, F; Clark, Re; Cortes, J; Deininger, M; Hughes, Tp; Janssen, J; Jiang, Q; Kim, Dw; Larson, Ra; Mahon, Fx; Mauro, M; Mayer, J; Nicolini, Fe; Pane, F; Rea, D; Richter, J; Rosti, G; Saglio, G; Hehlmann, R
Deep Molecular Response Rate in Chronic Phase Chronic Myeloid Leukemia: Eligibility to Discontinuation Related to Time to Response and Different Frontline TKI in the Experience of the Gimema Labnet CML National Network
2025 Breccia, M.; Cucci, R.; Marsili, G.; Castagnetti, F.; Galimberti, S.; Izzo, B.; Sorà, F.; Soverini, S.; Messina, M.; Piciocchi, A.; Bonifacio, M.; Cilloni, D.; Iurlo, A.; Martinelli, G.; Rosti, G.; Stagno, F.; Fazi, P.; Vignetti, M.; Pane, F.
Outcome of Chronic Myeloid Leukemia Patients Not in Deep Molecular Response: Results From the GIMEMA LabNet CML Network Database
2025 Stagno, F.; Cucci, R.; Marsili, G.; Castagnetti, F.; Galimberti, S.; Izzo, B.; Sorà, F.; Soverini, S.; Messina, M.; Piciocchi, A.; Bonifacio, M.; Cilloni, D.; Iurlo, A.; Martinelli, G.; Rosti, G.; Fazi, P.; Vignetti, M.; Breccia, M.; Allegra, A.; Pane, F.
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability
2025 Mancini, Manuela; De Santis, Sara; Monaldi, Cecilia; Castagnetti, Fausto; Iezza, Miriam; Iurlo, Alessandra; Cattaneo, Daniele; Galimberti, Sara; Cerrano, Marco; Capodanno, Isabella; Bonifacio, Massimiliano; Rossi, Maura; Agostinelli, Claudio; Meggendorfer, Manja; Haferlach, Torsten; Cavo, Michele; Gugliotta, Gabriele; Soverini, Simona
Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis
2024 Sciumè, Mariarita; Serpenti, Fabio; Zanotti, Roberta; Bonadonna, Patrizia; Tanasi, Ilaria; Crosera, Lara; Elena, Chiara; Mannelli, Francesco; Crupi, Francesca; Papayannidis, Cristina; Sartor, Chiara; Soverini, Simona; Rondoni, Michela; Eller‐Vainicher, Cristina; Pravettoni, Valerio; Rivolta, Federica; Alberti Violetti, Silvia; Croci, Giorgio Alberto; Migliorini, Anna Chiara; Bolli, Niccolò; Giannarelli, Diana; Grifoni, Federica Irene
Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia
2024 Forte, D.; Pellegrino, R. M.; Falvo, P.; Garcia-Gonzalez, P.; Alabed, H. B. R.; Maltoni, F.; Lombardi, D.; Bruno, S.; Barone, M.; Pasini, F.; Fabbri, F.; Vannini, I.; Donati, B.; Cristiano, G.; Sartor, C.; Ronzoni, S.; Ciarrocchi, A.; Buratta, S.; Urbanelli, L.; Emiliani, C.; Soverini, S.; Catani, L.; Bertolini, F.; Argüello, R. J.; Cavo, M.; Curti, A.
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets
2024 Bruno, S.; Borsi, E.; Patuelli, A.; Bandini, L.; Mancini, M.; Forte, D.; Nanni, J.; Barone, M.; Grassi, A.; Cristiano, G.; Venturi, C.; Robustelli, V.; Atzeni, G.; Mosca, C.; De Santis, S.; Monaldi, C.; Poletti, A.; Terragna, C.; Curti, A.; Cavo, M.; Soverini, S.; Ottaviani, E.
Unstable major molecular response as a trigger for next generation sequencing-based BCR::ABL1 mutation testing in chronic myeloid leukemia
2024 Benesova, A.; De Santis, S.; Polivkova, V.; Pecherkova, P.; Krizkova, J.; Suchankova, P.; Monaldi, C.; Klamova, H.; Srbova, D.; Zizkova, H.; Hochhaus, A.; Soverini, S.; Machova Polakova, K.
European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia
2023 Cross N.C.P.; Ernst T.; Branford S.; Cayuela J.-M.; Deininger M.; Fabarius A.; Kim D.D.H.; Machova Polakova K.; Radich J.P.; Hehlmann R.; Hochhaus A.; Apperley J.F.; Soverini S.
Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights
2023 Iezza M.; Cortesi S.; Ottaviani E.; Mancini M.; Venturi C.; Monaldi C.; De Santis S.; Testoni N.; Soverini S.; Rosti G.; Cavo M.; Castagnetti F.
Resistance mutations in CML and how we approach them
2023 Soverini S.
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted
2023 Mancini M.; Monaldi C.; De Santis S.; Papayannidis C.; Rondoni M.; Sartor C.; Bruno S.; Pagano L.; Criscuolo M.; Zanotti R.; Bonifacio M.; Tosi P.; Arock M.; Valent P.; Cavo M.; Soverini S.
Single-Cell Metabolic Profiling Integrated with Extracellular Vesicle Analysis Reveals Novel Metabolic Vulnerabilities and Prognostic Biomarkers in Acute Myeloid Leukemia
2023 Forte, D; Maltoni, F; Bruno, S; Garcia-Gonzalez, P; Cristiano, G; Sartor, C; Soverini, S; Catani, L; Argüello, Rj; Cavo, M; Curti, A
CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies
2022 Bruno S.; Ghelli Luserna di Rora A.; Napolitano R.; Soverini S.; Martinelli G.; Simonetti G.
CML-184 A Novel Droplet Digital PCR Strategy for Rapid and Sensitive Detection of BCR::ABL1 Kinase Domain Mutations Conferring Resistance to Second-Generation Tyrosine Kinase Inhibitors
2022 de Santis S.; Monaldi C.; Martelli M.; Mancini M.; Bruno S.; Castagnetti F.; Gugliotta G.; Polakova K.M.; Ernst T.; Maar D.; Corner A.; Cavo M.; Soverini S.
Combined Inhibition of Polo-like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells
2022 Mancini M.; Monaldi C.; De Santis S.; Rondoni M.; Papayannidis C.; Sartor C.; Curti A.; Bruno S.; Cavo M.; Soverini S.
Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia
2022 Soverini, S.; De Santis, S.; Martelli, M.; Monaldi, C.; Castagnetti, F.; Gugliotta, G.; Papayannidis, C.; Mancini, M.; Bruno, S.; Venturi, C.; Machova Polakova, K.; Ernst, T.; Maar, D.; Corner, A.; Cavo, M.
MPN-182 Droplet Digital PCR for Non-Invasive Detection of the KIT D816V Mutation in the Peripheral Blood of Patients With Suspected Systemic Mastocytosis
2022 Monaldi C.; de Santis S.; Mancini M.; Papayannidis C.; Sartor C.; Rondoni M.; Bruno S.; Cavo M.; Soverini S.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| How I evaluate and treat resistance and relapse in CML | Soverini, S.; Castagnetti, F. | 2026-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Nilotinib versus imatinib with early switch from imatinib to nilotinib to obtain treatment-free remission in newly diagnosed chronic myeloid leukemia patients: the analysis of the first co-primary endpoint | Castagnetti, F.; Breccia, M.; Abruzzese, E.; Bassan, R.; Binotto, G.; Bonifacio, M.; Caocci, G.; ...Capodanno, I.; Cavazzini, F.; Cimino, G.; Fazi, P.; Gozzini, A.; Iurlo, A.; Janssen, J. J. W. M.; Lunghi, M.; Marasca, R.; Martino, B.; Messina, M.; Muriano, F.; Paoloni, F.; Piciocchi, A.; Rosti, G.; Russo Rossi, A.; Saglio, G.; Sica, S.; Soverini, S.; Tafuri, A.; Vallisa, D.; Westerweel, P. E.; Pane, F. | 2026-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | unpaywall-bitstream--1005548311.pdf; 41375_2025_2796_MOESM1_ESM.docx |
| 2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia | Apperley, Jf; Milojkovic, D; Cross, Ncp; Hjorth-Hansen, H; Hochhaus, A; Kantarjian, H; Lipton, Jh...; Malhotra, H; Niederwieser, D; Radich, J; Rousselot, P; Saussele, S; Schiffer, Ca; Silver, R; Soverini, S; Stenke, L; Turkina, A; Casado, Lf; Castagnetti, F; Cervantes, F; Clark, Re; Cortes, J; Deininger, M; Hughes, Tp; Janssen, J; Jiang, Q; Kim, Dw; Larson, Ra; Mahon, Fx; Mauro, M; Mayer, J; Nicolini, Fe; Pane, F; Rea, D; Richter, J; Rosti, G; Saglio, G; Hehlmann, R | 2025-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | unpaywall-bitstream--1281678054.pdf |
| Deep Molecular Response Rate in Chronic Phase Chronic Myeloid Leukemia: Eligibility to Discontinuation Related to Time to Response and Different Frontline TKI in the Experience of the Gimema Labnet CML National Network | Breccia, M.; Cucci, R.; Marsili, G.; Castagnetti, F.; Galimberti, S.; Izzo, B.; Sorà, F.; Soverin...i, S.; Messina, M.; Piciocchi, A.; Bonifacio, M.; Cilloni, D.; Iurlo, A.; Martinelli, G.; Rosti, G.; Stagno, F.; Fazi, P.; Vignetti, M.; Pane, F. | 2025-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Outcome of Chronic Myeloid Leukemia Patients Not in Deep Molecular Response: Results From the GIMEMA LabNet CML Network Database | Stagno, F.; Cucci, R.; Marsili, G.; Castagnetti, F.; Galimberti, S.; Izzo, B.; Sorà, F.; Soverini..., S.; Messina, M.; Piciocchi, A.; Bonifacio, M.; Cilloni, D.; Iurlo, A.; Martinelli, G.; Rosti, G.; Fazi, P.; Vignetti, M.; Breccia, M.; Allegra, A.; Pane, F. | 2025-01-01 | AMERICAN JOURNAL OF HEMATOLOGY | - | 1.01 Articolo in rivista | Stagno_AJH_2025.pdf |
| SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability | Mancini, Manuela; De Santis, Sara; Monaldi, Cecilia; Castagnetti, Fausto; Iezza, Miriam; Iurlo, A...lessandra; Cattaneo, Daniele; Galimberti, Sara; Cerrano, Marco; Capodanno, Isabella; Bonifacio, Massimiliano; Rossi, Maura; Agostinelli, Claudio; Meggendorfer, Manja; Haferlach, Torsten; Cavo, Michele; Gugliotta, Gabriele; Soverini, Simona | 2025-01-01 | CLINICAL AND TRANSLATIONAL MEDICINE | - | 1.01 Articolo in rivista | - |
| Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis | Sciumè, Mariarita; Serpenti, Fabio; Zanotti, Roberta; Bonadonna, Patrizia; Tanasi, Ilaria; Croser...a, Lara; Elena, Chiara; Mannelli, Francesco; Crupi, Francesca; Papayannidis, Cristina; Sartor, Chiara; Soverini, Simona; Rondoni, Michela; Eller‐Vainicher, Cristina; Pravettoni, Valerio; Rivolta, Federica; Alberti Violetti, Silvia; Croci, Giorgio Alberto; Migliorini, Anna Chiara; Bolli, Niccolò; Giannarelli, Diana; Grifoni, Federica Irene | 2024-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia | Forte, D.; Pellegrino, R. M.; Falvo, P.; Garcia-Gonzalez, P.; Alabed, H. B. R.; Maltoni, F.; Lomb...ardi, D.; Bruno, S.; Barone, M.; Pasini, F.; Fabbri, F.; Vannini, I.; Donati, B.; Cristiano, G.; Sartor, C.; Ronzoni, S.; Ciarrocchi, A.; Buratta, S.; Urbanelli, L.; Emiliani, C.; Soverini, S.; Catani, L.; Bertolini, F.; Argüello, R. J.; Cavo, M.; Curti, A. | 2024-01-01 | NATURE COMMUNICATIONS | - | 1.01 Articolo in rivista | s41467-024-55231-9 (2).pdf; 41467_2024_55231_MOESM4_ESM.zip |
| Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets | Bruno, S.; Borsi, E.; Patuelli, A.; Bandini, L.; Mancini, M.; Forte, D.; Nanni, J.; Barone, M.; G...rassi, A.; Cristiano, G.; Venturi, C.; Robustelli, V.; Atzeni, G.; Mosca, C.; De Santis, S.; Monaldi, C.; Poletti, A.; Terragna, C.; Curti, A.; Cavo, M.; Soverini, S.; Ottaviani, E. | 2024-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-25-10002-v2.pdf; ijms-25-10002-s001.zip |
| Unstable major molecular response as a trigger for next generation sequencing-based BCR::ABL1 mutation testing in chronic myeloid leukemia | Benesova, A.; De Santis, S.; Polivkova, V.; Pecherkova, P.; Krizkova, J.; Suchankova, P.; Monaldi..., C.; Klamova, H.; Srbova, D.; Zizkova, H.; Hochhaus, A.; Soverini, S.; Machova Polakova, K. | 2024-01-01 | AMERICAN JOURNAL OF HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia | Cross N.C.P.; Ernst T.; Branford S.; Cayuela J.-M.; Deininger M.; Fabarius A.; Kim D.D.H.; Machov...a Polakova K.; Radich J.P.; Hehlmann R.; Hochhaus A.; Apperley J.F.; Soverini S. | 2023-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | s41375-023-02048-y-4.pdf |
| Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights | Iezza M.; Cortesi S.; Ottaviani E.; Mancini M.; Venturi C.; Monaldi C.; De Santis S.; Testoni N.;... Soverini S.; Rosti G.; Cavo M.; Castagnetti F. | 2023-01-01 | CELLS | - | 1.01 Articolo in rivista | cells-12-01703-v2.pdf |
| Resistance mutations in CML and how we approach them | Soverini S. | 2023-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
| SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted | Mancini M.; Monaldi C.; De Santis S.; Papayannidis C.; Rondoni M.; Sartor C.; Bruno S.; Pagano L....; Criscuolo M.; Zanotti R.; Bonifacio M.; Tosi P.; Arock M.; Valent P.; Cavo M.; Soverini S. | 2023-01-01 | BIOMARKER RESEARCH | - | 1.01 Articolo in rivista | Mancini_2023.pdf; 40364_2023_468_MOESM1_ESM.docx |
| Single-Cell Metabolic Profiling Integrated with Extracellular Vesicle Analysis Reveals Novel Metabolic Vulnerabilities and Prognostic Biomarkers in Acute Myeloid Leukemia | Forte, D; Maltoni, F; Bruno, S; Garcia-Gonzalez, P; Cristiano, G; Sartor, C; Soverini, S; Catani,... L; Argüello, Rj; Cavo, M; Curti, A | 2023-01-01 | BLOOD | ELSEVIER | 4.01 Contributo in Atti di convegno | - |
| CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies | Bruno S.; Ghelli Luserna di Rora A.; Napolitano R.; Soverini S.; Martinelli G.; Simonetti G. | 2022-01-01 | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | Bruno_JECCR_2022.pdf; 13046_2022_2363_MOESM1_ESM.docx |
| CML-184 A Novel Droplet Digital PCR Strategy for Rapid and Sensitive Detection of BCR::ABL1 Kinase Domain Mutations Conferring Resistance to Second-Generation Tyrosine Kinase Inhibitors | de Santis S.; Monaldi C.; Martelli M.; Mancini M.; Bruno S.; Castagnetti F.; Gugliotta G.; Polako...va K.M.; Ernst T.; Maar D.; Corner A.; Cavo M.; Soverini S. | 2022-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Combined Inhibition of Polo-like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells | Mancini M.; Monaldi C.; De Santis S.; Rondoni M.; Papayannidis C.; Sartor C.; Curti A.; Bruno S.;... Cavo M.; Soverini S. | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-14-00738.pdf; cancers-14-00738-s001.zip |
| Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia | Soverini, S.; De Santis, S.; Martelli, M.; Monaldi, C.; Castagnetti, F.; Gugliotta, G.; Papayanni...dis, C.; Mancini, M.; Bruno, S.; Venturi, C.; Machova Polakova, K.; Ernst, T.; Maar, D.; Corner, A.; Cavo, M. | 2022-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| MPN-182 Droplet Digital PCR for Non-Invasive Detection of the KIT D816V Mutation in the Peripheral Blood of Patients With Suspected Systemic Mastocytosis | Monaldi C.; de Santis S.; Mancini M.; Papayannidis C.; Sartor C.; Rondoni M.; Bruno S.; Cavo M.; ...Soverini S. | 2022-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |